Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-17

Clinical Trial Update: The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing whether astaxanthin supplementation improves clinical symptoms and cardio-metabolic parameters in women with Polycystic Ovary S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Astaxanthin

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: PCO - Polycystic Ovaries, Obesity and Obesity-related Medical Conditions | Phase 1 | Status: RECRUITING